RxDoctor Payments Data

Ashley Wallner, NP

Family · Minot, NDNPI 1952748923

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 85.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $2,003, more than ten times the $20 reported in 2021. Among family clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,198in general payments, 2019–2025

Across 34 payments — averaging $64.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Seagen Inc.$100
  • Coloplast$69
  • Galderma Laboratories, L.p.$41
  • Pfizer$37
  • Merck$26
  • plus $55 from 3 others

What the payments were for

  • Travel & lodging$1,08249%
  • Food & beverage$98045%
  • Education$1366%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,198 in reported general payments places this provider in the 90th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$60,729
Medicare patients
608
Services billed
1,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron139$92,984
Estradiol118$10,641
Trospium Chloride67$5,711
Tamsulosin Hcl351$5,543
Finasteride363$4,950
Methenamine Hippurate41$4,021
Oxybutynin Chloride ErOxybutynin Chloride121$2,995
Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl11$1,858
Oxybutynin Chloride91$1,396
Potassium Citrate ErPotassium Citrate11$1,157
Alfuzosin Hcl ErAlfuzosin Hcl11$417
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst20$330
Solifenacin Succinate13$254
Doxycycline Hyclate11$224
Ciprofloxacin Hcl72$185

Paid to pharmacies, not to this prescriber.

Other family in Minot

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →